Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06988527

Treatment Outcomes and Patient Satisfaction of Oral Lichen Planus Treatment

Status
Recruiting
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
56 (estimated)
Sponsor
Dar Al Uloom University · Academic / Other
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to assess Honey in orabase (1:1) for treating patients with OLP and improving their quality of life: The research question aims to answer: Does honey in orabase (1:1) improve or reduce OLP symptoms compared to the standardized treatment by triamcinolone acetonide 0.1% drug and improve the patient's quality of life? Participants will: Take drug ABC or a placebo every day for 4 months Visit the clinic once every 2 weeks for checkups and tests Keep a diary of their symptoms and the number of times they use a rescue inhaler

Detailed description

The study comprised 56 patients diagnosed with Oral Lichen Planus, who were randomly selected according to inclusion and exclusion criteria. The subjects were between 35 and 60 years old, capable of complying with the study procedure, and provided informed consent. Exclusion criteria encompassed those with alternative oral mucosal illnesses, systemic problems influencing OLP or wound healing, allergies or sensitivities to honey or triamcinolone, or those receiving systemic corticosteroids or immunosuppressive drugs. Individuals who were pregnant or lactating, as well as those unable to provide informed written consent, were excluded.

Conditions

Interventions

TypeNameDescription
DRUGHoney in orabase 1: 1 pasteThe experimental drug was manufactured and packed at the Faculty of Pharmacy, Price Sattam University, SA. Production of a mucoadhesive paste involves a step-by-step process. in the final step, honey, comprising 50% of the total composition was thoroughly blended with the prepared base to ensure homogeneity

Timeline

Start date
2025-05-20
Primary completion
2026-06-15
Completion
2026-06-30
First posted
2025-05-25
Last updated
2026-02-17

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT06988527. Inclusion in this directory is not an endorsement.